Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance

Trends in Immunology

Volumn 30, Issue 10, 2009, Pages 488-493

  Pillai, Shiv ^a   Cariappa, Annaiah ^a   Pirnie, Stephan P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; ESTERASE; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; RAG1 PROTEIN; RAG2 PROTEIN; SIALIC ACID ACETYLESTERASE; SIALIC ACID DERIVATIVE; SIGLEC PROTEIN; UNCLASSIFIED DRUG;

AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL LINEAGE; CELL SELECTION; CELLULAR DISTRIBUTION; CLONAL ANERGY; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; ONTOGENY; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CARBOHYDRATE METABOLISM; CARBOXYLIC ESTER HYDROLASES; CLONAL DELETION; DOWN-REGULATION; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; N-ACETYLNEURAMINIC ACID; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, INTERLEUKIN-4; SRC-FAMILY KINASES;

EID: 70349559578     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.07.006     Document Type: Review

References (45)

1. Verdine G.L., and Walensky L.D. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. Clin Cancer Res 13 24 (2007) 7264-7270
2. Cariappa A., et al. B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med 206 1 (2009) 125-138
3. Lam K.P., et al. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90 6 (1997) 1073-1083
4. Kraus M., et al. Survival of resting mature B lymphocytes depends on BCR signaling via the Ig alpha/beta heterodimer. Cell 117 6 (2004) 787-800
5. Tze L.E., et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol 3 3 (2005) e82
6. Pillai S., et al. Marginal zone B cells. Annu Rev Immunol 23 (2005) 161-196
7. Gay D., et al. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 177 4 (1993) 999-1008
8. Tiegs S.L., et al. Receptor editing in self-reactive bone-marrow B cells. J Exp Med 177 (1993) 1009-1020
9. Nemazee D.A., and Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337 6207 (1989) 562-566
10. Hartley S.B., et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353 6346 (1991) 765-769
11. Hartley S.B., et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72 3 (1993) 325-335
12. Goodnow C.C., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334 6184 (1988) 676-682
13. Cyster J.G., et al. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371 6496 (1994) 389-395
14. Ekland E.H., et al. Requirements for follicular exclusion and competitive elimination of autoantigen-binding B cells. J Immunol 172 8 (2004) 4700-4708
15. Pelanda R., et al. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity 7 6 (1997) 765-775
16. Halverson R., et al. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol 5 6 (2004) 645-650
17. Hippen K.L., et al. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J Immunol 175 2 (2005) 909-916
18. Wardemann H., et al. Predominant autoantibody production by early human B cell precursors. Science 301 5638 (2003) 1374-1377
19. Panigrahi A.K., et al. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med 205 13 (2008) 2985-2994
20. Kumar K.R., et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312 5780 (2006) 1665-1669
21. Crocker P.R., et al. Siglecs and their roles in the immune system. Nat Rev Immunol 7 4 (2007) 255-266
22. Powell L.D., et al. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem 268 10 (1993) 7019-7027
23. Otipoby K.L., et al. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384 6610 (1996) 634-637
24. O'Keefe T.L., et al. Hyperresponsive B cells in CD22-deficient mice. Science 274 5288 (1996) 798-801
25. Sato S., et al. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5 6 (1996) 551-562
26. Nitschke L., et al. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7 2 (1997) 133-143
27. Peaker C.J., and Neuberger M.S. Association of CD22 with the B cell antigen receptor. Eur J Immunol 23 6 (1993) 1358-1363
28. Walker J.A., and Smith K.G. CD22: an inhibitory enigma. Immunology 123 3 (2008) 314-325
29. Collins B.E., et al. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat Immunol 7 2 (2006) 199-206
30. Stoddart A., et al. Molecular cloning of the cDNA encoding a murine sialic acid-specific 9-O-acetylesterase and RNA expression in cells of hematopoietic and non-hematopoietic origin. Nucleic Acids Res 24 20 (1996) 4003-4008
31. Takematsu H., et al. Lysosomal and cytosolic sialic acid 9-O-acetylesterase activities can be encoded by one gene via differential usage of a signal peptide-encoding exon at the N terminus. J Biol Chem 274 36 (1999) 25623-25631
32. Sjoberg E.R., et al. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids. J Cell Biol 126 2 (1994) 549-562
33. Blixt O., et al. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J Biol Chem 278 33 (2003) 31007-31019
34. Naito Y., et al. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol 27 8 (2007) 3008-3022
35. Cariappa A., et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14 5 (2001) 603-615
36. Cariappa A., et al. Perisinusoidal B cells in the bone marrow participate in T-independent responses to blood-borne microbes. Immunity 23 4 (2005) 397-407
37. Ghosh S., et al. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids. Int Immunol 18 (2006) 603-611
38. O'Keefe T.L., et al. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189 8 (1999) 1307-1313
39. Hibbs M.L., et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83 2 (1995) 301-311
40. Pao L.I., et al. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27 1 (2007) 35-48
41. Hoffmann A., et al. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol 8 7 (2007) 695-704
42. Chen G.Y., et al. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323 5922 (2009) 1722-1725
43. Gross A.J., et al. Developmental acquisition of the Lyn-CD22-SHP-1inhibitory pathway promotes B cell tolerance. J Immunol 182 (2009) 5382-5392
44. Cornall R.J., et al. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8 (1998) 497-508
45. Lanoue A., et al. Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity?. Eur J Immunol 32 (2002) 348-355